Chronic liver allograft dysfunction
- PMID: 19328977
- DOI: 10.1016/j.transproceed.2009.01.038
Chronic liver allograft dysfunction
Abstract
Approximately 90% of liver transplant patients are alive after 1 year and 75% after 5 years with the majority leading full and near-normal lives. However, although early mortality rates after transplantation have fallen dramatically over the last 2 decades, the rates of late graft loss and patient death have remained constant. Thus, understanding of the causes of graft and patient failure is essential to improve long-term outcomes. In the early days after liver transplantation, ischemia and reperfusion injuries predominate, with acute cellular rejection relatively common in first 3 months. Thereafter, the causes of graft dysfunction are variable with disease recurrence as a major cause of graft loss. In this review, we discuss causes of graft dysfunction after 6 months.
Similar articles
-
Analysis of causes of death in liver transplant recipients who survived more than 3 years.Liver Transpl. 2001 Sep;7(9):811-5. doi: 10.1053/jlts.2001.27084. Liver Transpl. 2001. PMID: 11552217
-
The natural history of hepatitis C cirrhosis after liver transplantation.Liver Transpl. 2009 Sep;15(9):1063-71. doi: 10.1002/lt.21784. Liver Transpl. 2009. PMID: 19718647
-
Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.Transplant Proc. 2009 Apr;41(3):1041-3. doi: 10.1016/j.transproceed.2009.02.030. Transplant Proc. 2009. PMID: 19376421
-
Molecular and cellular aspects of hepatitis C virus reinfection after liver transplantation: how the early phase impacts on outcomes.Transplantation. 2009 Apr 27;87(8):1105-11. doi: 10.1097/TP.0b013e31819dfa83. Transplantation. 2009. PMID: 19384153 Review.
-
Recurrence of diseases following orthotopic liver transplantation.Am J Gastroenterol. 2006 Jun;101(6):1370-8. doi: 10.1111/j.1572-0241.2006.00586.x. Am J Gastroenterol. 2006. PMID: 16771963 Review.
Cited by
-
De novo autoimmune hepatitis following liver transplantation for primary biliary cirrhosis: an unusual cause of late grafts dysfunction.Pan Afr Med J. 2015 May 4;21:2. doi: 10.11604/pamj.2015.21.2.6789. eCollection 2015. Pan Afr Med J. 2015. PMID: 26401196 Free PMC article.
-
Flow cessation triggers endothelial dysfunction during organ cold storage conditions: strategies for pharmacologic intervention.Transplantation. 2010 Jul 27;90(2):142-9. doi: 10.1097/TP.0b013e3181e228db. Transplantation. 2010. PMID: 20606606 Free PMC article.
-
Histological and Clinicopathological Evaluation of Liver Allograft Biopsy: An Initial Experience of Fifty Six Biopsies.J Clin Diagn Res. 2015 Nov;9(11):EC17-20. doi: 10.7860/JCDR/2015/13664.6812. Epub 2015 Nov 1. J Clin Diagn Res. 2015. PMID: 26673862 Free PMC article.
-
A Comprehensive Review of Liver Allograft Fibrosis and Steatosis: From Cause to Diagnosis.Transplant Direct. 2023 Oct 16;9(11):e1547. doi: 10.1097/TXD.0000000000001547. eCollection 2023 Nov. Transplant Direct. 2023. PMID: 37854023 Free PMC article. Review.
-
High relevance of invasive fungal disease in chronic liver transplant failure: a comprehensive cross-sectional study.Virchows Arch. 2025 Aug;487(2):413-422. doi: 10.1007/s00428-025-04050-4. Epub 2025 Feb 18. Virchows Arch. 2025. PMID: 39966110 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical